LUDG   $0.12  0.84% Market Open


Current temperature: 0.00
ST: 0, Cor:

ISIN US54973P4019
ceo Dr. Marvin S. Hausman M.D.
Website https://www.ludwigent.com
Ludwig Enterprises, Inc. operates as a genomic technology and health related company. The company engages in the developing of products that use inflammatory genetic markers to assess the occurrence of inflammation and inflammation related diseases, as well as monitor treatment responses. It offers My RNA for Life Home Test Kits, that identify the potential to develop chronic inflammatory diseases, such as cancer and heart disease; and My RNA for Life Genetic Centric Supplement, that may modulate a person's previously measured inflammatory index or even potentially control further inflammatory reactions and continued disease development. In addition, the company develop a medical machine learning artificial intelligence technology that uses mRNA inflammatory language to capture an inflammatory snapshot of disease and the body's response to treatment. Ludwig Enterprises, Inc. was incorporated in 2006 and is based in Sparks, Nevada.